Skip to content

Clinical trials

Mucopolysaccharidosis IV trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Mucopolysaccharidosis IV Country / region: United Kingdom Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20091
20101
20113
20123
20141
20161
20191
20201
20211
20221
20232
20242
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Terminated4
Enrolling by invitation3
Recruiting3
Active, not recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
BioMarin Pharmaceutical9
QED Therapeutics, a BridgeBio company8
University of Nottingham2
Birmingham Women's and Children's NHS Foundation Trust1
Mr Ryckie George Wade1
University of Bath1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Mucopolysaccharidosis IV22
Bone Diseases8
Lysosomal Storage Diseases8
Musculoskeletal Diseases8
Osteochondrodysplasias8
Dwarfism7
Genetic Diseases, Inborn7
Achondroplasia5
Irritable Bowel Syndrome2
Bone Diseases, Developmental1

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.